Drug release testing methods of polymeric particulate drug formulations

Journal of Pharmaceutical Investigation

Volumn 43, Issue 4, 2013, Pages 259-266

  Amatya, Sarmila ^a   Park, Eun Ji ^b   Park, Jong Hoon ^c   Kim, Joon Sik ^c   Seol, Eunyoung ^c   Lee, Heeyong ^c   Choi, Hoil ^c   Shin, Young Hee ^a   Na, Dong Hee ^b  

^a Kyungsung University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Peptron Inc   (South Korea)

Author keywords

In vitro drug release test; Microparticles; Sustained release formulations

Indexed keywords

ANGIOPEPTIN; BUPIVACAINE; BUSERELIN; BUSERELIN ACETATE; DEXAMETHASONE; EXENDIN 4; LEUPRORELIN; MINOCYCLINE; NALTREXONE; OCTREOTIDE; POLYGLACTIN; POLYMER; RISPERIDONE; TRIPTORELIN;

ACROMEGALY; ALCOHOLISM; ANALYTIC METHOD; DIALYSIS; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE MICROPARTICLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SCHIZOPHRENIA; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84880677157     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-013-0072-5     Document Type: Review

References (49)

1. Ahmed TA, Ibrahim HM, Ibrahim F, Samy AM, Kaseem A, Nutan MT, Hussain MD (2012) Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol. J Pharm Sci 101: 3753-3762.
2. Anderson JM, Shive MS (1997) Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 28: 5-24.
3. Asadishad B, Vossoughi M, Alamzadeh I (2010) In vitro release behavior and cytotoxicity of doxorubicin-loaded gold nanoparticles in cancerous cells. Biotechnol Lett 32: 649-654.
4. Aubert-Pouëssel A, Venier-Julienne MC, Clavreul A, Sergent M, Jollivet C, Montero-Menei CN, Garcion E, Bibby DC, Menei P, Benoit JP (2004) In vitro study of GDNF release from biodegradable PLGA microspheres. J Control Release 95: 463-475.
5. Bodmeier R, McGinity JW (1987) The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method. Pharm Res 4: 465-471.
6. Brown CK, Friedel HD, Barker AR, Buhse LF, Keitel S, Cecil TL, Kraemer J, Morris JM, Reppas C, Stickelmeyer MP, Yomota C, Shah VP (2011) FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech 12: 782-794.
7. Choi JS, Seo K, Yoo JW (2012) Recent advances in PLGA particulate systems for drug delivery. J Pharm Invest 42: 155-163.
8. Cleland JL (1995) Design and production of single immunization vaccines using polylactide polyglycolide microsphere systems. In: Powell MF, Newman MJ (eds) Vaccine Design. Plenum, New York, pp 439-472.
9. Conti B, Genta I, Giunchedi P, Modena T (1995) Testing of "in vitro" dissolution behavior of microparticulate drug delivery systems. Drug Dev Ind Pharm 21: 1223-1233.
10. D'Souza SS, DeLuca PP (2005) Development of a dialysis in vitro release method for biodegradable microspheres. AAPS PharmSciTech 6: E323-E328.
11. D'Souza SS, DeLuca PP (2006) Methods to assess in vitro drug release from injectable polymeric particulate systems. Pharm Res 23: 460-474.
12. D'Souza SS, Faraj JA, DeLuca PP (2005) A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres. AAPS PharmSciTech 6: E553-E564.
13. Gombotz WR, Pettit DK (1995) Biodegradable polymers for protein and peptide drug delivery. Bioconjug Chem 6: 332-351.
14. Guerrero S, Muñíz E, Teijón C, Olmo R, Teijón JM, Blanco MD (2008) Ketotifen-loaded microspheres prepared by spray-drying poly(d, l-lactide) and poly(d, l-lactide-co-glycolide) polymers: characterization and in vivo evaluation. J Pharm Sci 97: 3153-3169.
15. Jeong YI, Song JG, Kang SS, Ryu HH, Lee YH, Choi C, Shin BA, Kim KK, Ahn KY, Jung S (2003) Preparation of poly(dl-lactide-co-glycolide) microspheres encapsulating all-trans retinoic acid. Int J Pharm 259: 79-91.
16. Kim H, Burgess DJ (2002) Effect of drug stability on the analysis of release data from controlled release microspheres. J Microencapsul 19: 631-640.
17. Kinget R, Bontinck AM, Herbots H (1979) Problems of dialysis techniques in the study of macromolecule binding of drugs. Int J Pharm 3: 65-72.
18. Klose D, Siepmann F, Elkharraz K, Siepmann J (2008) PLGA-based drug delivery systems: importance of the type of drug and device geometry. Int J Pharm 354: 95-103.
19. Larsen DB, Joergensen S, Olsen NV, Hansen SH, Larsen C (2002) In vivo release of bupivacaine from subcutaneously administered oily solution. Comparison with in vitro release. J Control Release 81: 145-154.
20. Larsen C, Larsen SW, Jensen H, Yaghmur A, Ostergaard J (2009) Role of in vitro release models in formulation development and quality control of parenteral depots. Expert Opin Drug Deliv 6: 1283-1295.
21. Liggins RT, Burt HM (2001) Paclitaxel loaded poly(l-lactic acid) microspheres: properties of microspheres made with low molecular weight polymers. Int J Pharm 222: 19-33.
22. Maestrelli F, Mura P, Alonso MJ (2004) Formulation and characterization of triclosan sub-micron emulsions and nanocapsules. J Microencapsul 21: 857-864.
23. Mitra A, Wu Y (2010) Use of in vitro-in vivo correlation (IVIVC) to facilitate the development of polymer-based controlled release injectable formulation. Recent Pat Drug Deliv Formul 4: 94-104.
24. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM (2008) Nano/micro technologies for delivering macromolecular therapeutics using poly(d, l-lactide-co-glycolide) and its derivatives. J Control Release 125: 193-209.
25. Murty SB, Goodman J, Thanoo BC, DeLuca PP (2003) Identification of chemically modified peptide from poly(d, l-lactide-co-glycolide) microspheres under in vitro release conditions. AAPS PharmSciTech 4: E50.
26. Murty SB, Na DH, Thanoo BC, DeLuca PP (2005) Impurity formation studies with peptide-loaded polymeric microspheres Part II. In vitro evaluation. Int J Pharm 297: 62-72.
27. Park EJ, Na DH, Lee KC (2007) In vitro release study of mono-PEGylated growth hormone-releasing peptide-6 from PLGA microspheres. Int J Pharm 343: 281-283.
28. Park JH, Ye M, Park K (2005) Biodegradable polymers for microencapsulation of drugs. Molecules 10: 146-161.
29. Park EJ, Amatya S, Kim MS, Park JH, Seol E, Lee H, Shin YH, Na DH (2013) Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia. Arch Pharm Res. doi: 10. 1007/s12272-013-0105-7.
30. Parshad H, Frydenvang K, Liljefors T, Cornett C, Larsen C (2003) Assessment of drug salt release from solutions, suspensions and in situ suspensions using a rotating dialysis cell. Eur J Pharm Sci 19: 263-272.
31. Rawat A, Burgess DJ (2011) USP apparatus 4 method for in vitro release testing of protein loaded microspheres. Int J Pharm 409: 178-184.
32. Rawat A, Stippler E, Shah VP, Burgess DJ (2011) Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal Consta. Int J Pharm 420: 198-205.
33. Rawat A, Bhardwaj U, Burgess DJ (2012) Comparison of in vitro-in vivo release of Risperdal Consta microspheres. Int J Pharm 434: 115-121.
34. Schoubben A, Blasi P, Deluca PP (2012) Effect of agitation regimen on the in vitro release of leuprolide from poly(lactic-co-glycolic) acid microparticles. J Pharm Sci 101: 1212-1220.
35. Schultz K, Møllgaard B, Frokjaer S, Larsen C (1997) Rotating dialysis cell as in vitro release method for oily parenteral depot solutions. Int J Pharm 157: 163-169.
36. Shen J, Burgess DJ (2012) Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings. Int J Pharm 422: 341-348.
37. Tunçay M, Caliş S, Kaş HS, Ercan MT, Peksoy I, Hincal AA (2000) Diclofenac sodium incorporated PLGA (50: 50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int J Pharm 195: 179-188.
38. Vandelli MA, Rivasi F, Guerra P, Forni F, Arletti R (2001) Gelatin microspheres crosslinked with d, l-glyceraldehyde as a potential drug delivery system: preparation, characterisation, in vitro and in vivo studies. Int J Pharm 215: 175-184.
39. Voisine JM, Zolnik BS, Burgess DJ (2008) In situ fiber optic method for long-term in vitro release testing of microspheres. Int J Pharm 356: 206-211.
40. Wagenaar BW, Müller BW (1994) Piroxicam release from spray-dried biodegradable microspheres. Biomaterials 15: 49-54.
41. Wang J, Wang BM, Schwendeman SP (2002) Characterization of the initial burst release of a model peptide from poly(d, l-lactide-co-glycolide) microspheres. J Control Release 82: 289-307.
42. Wei G, Pettway GJ, McCauley LK, Ma PX (2004) The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials 25: 345-352.
43. Wischke C, Schwendeman SP (2008) Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 364: 298-327.
44. Xu Q, Hashimoto M, Dang TT, Hoare T, Kohane DS, Whitesides GM, Langer R, Anderson DG (2009) Preparation of monodisperse biodegradable polymer microparticles using a microfluidic flow-focusing device for controlled drug delivery. Small 5: 1575-1581.
45. Xu X, Khan MA, Burgess DJ (2012) A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes. Int J Pharm 426: 211-218.
46. Yang YY, Chia HH, Chung TS (2000) Effect of preparation temperature on the characteristics and release profiles of PLGA microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. J Control Release 69: 81-96.
47. Yen SY, Sung KC, Wang JJ, Yoa-Pu Hu O (2001) Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies. Int J Pharm 220: 91-99.
48. Zolnik BS, Burgess DJ (2008) Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release 127: 137-145.
49. Zolnik BS, Leary PE, Burgess DJ (2006) Elevated temperature accelerated release testing of PLGA microspheres. J Control Release 112: 293-300.